Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
about
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Health Equity Considerations f ...... Equity Special Interest Group.
@en
Health Equity Considerations f ...... Equity Special Interest Group.
@nl
type
label
Health Equity Considerations f ...... Equity Special Interest Group.
@en
Health Equity Considerations f ...... Equity Special Interest Group.
@nl
prefLabel
Health Equity Considerations f ...... Equity Special Interest Group.
@en
Health Equity Considerations f ...... Equity Special Interest Group.
@nl
P2093
P2860
P50
P356
P1476
Health Equity Considerations f ...... Equity Special Interest Group.
@en
P2093
Anne Lyddiatt
Annelies Boonen
Antoine G Sreih
Beverley Shea
Caroline Flurey
Catherine Hofstetter
Charles H Goldsmith
Cheryl Barnabe
Christie M Bartels
Christoph Pohl
P2860
P304
P356
10.3899/JRHEUM.160975
P407
P577
2017-02-15T00:00:00Z